Brian Duperreault to Receive City of Hope's 'The Spirit of Life' Award.

Business Editors/Banking & Insurance Writers

CHICAGO--(BUSINESS WIRE)--June 29, 2000

Brian Duperreault, Chairman and CEO of ACE Limited, a Bermuda-based insurance and reinsurance company, will be awarded City of Hope's most coveted honor, The Spirit of Life Award, for his outstanding contributions to his industry and community.

The National Insurance Council of City of Hope will present this honor on November 9, 2000 at the Sheraton Chicago Hotel. Proceeds benefit breast cancer research at the City of Hope National Medical Center and Beckman Research Institute.

Mr. Duperreault joined ACE Limited as chairman, president and CEO in October of 1994. He has overseen ACE's growth from a small catastrophe insurer with operations in three countries to a broadly diversified global company doing business in almost 50 countries.

Prior to joining ACE, Mr. Duperreault was the executive vice president of Foreign General Insurance of American International Group, Inc. (AIG), and concurrently, chief executive officer of American International Underwriters (AIU).

Mr. Duperreault, a Bermudian, holds a B.S. degree in Mathematics from Saint Joseph's University in Philadelphia. He is a member of the Board of Trustees of Saint Joseph's University and The College of Insurance in New York.

The Insurance Industry Council has supported City of Hope activities for more than 20 years. In the last seven years, the Council has channeled its donations to the institution's breast cancer research programs. More than $4.5 million has been generated by the industry-wide effort since 1993 to help City of Hope battle one of the world's major health problems.

Currently, there are some 2.6 million women with breast cancer in the U.S. alone, yet nearly one million are unaware that they have the disease. City of Hope is conducting a number of promising clinical trials to redefine the standards of care for breast cancer patients at medical centers nationwide.

This research involves establishing innovative breast cancer research protocols, including bone marrow transplantation (BMT), new anti-cancer drugs, radiation therapy, breast conserving surgery, gene therapy, immunologic treatments and quality-of-life studies.

The Breast Cancer Research Program, funded in part by the National Cancer Institute, explores new horizons and sets new standards for breast cancer prevention, early detection, and treatment.

The City of Hope National Medical Center and Beckman Research Institute, a National Cancer Institute-designated Comprehensive Cancer Center, is one of the world's leading research and treatment centers for cancer and other serious diseases, including diabetes and HIV/AIDS.

The work conducted at City of Hope is shared with medical centers worldwide, touching the lives of millions of people everywhere. City of Hope is located in Greater Los Angeles.

For more information about how you can support City of Hope's lifesaving research and treatment programs, please call 1-800/779-5893, or visit the Web site at www.cityofhope.org. City of Hope, Where the Power of Knowledge Saves Lives(TM).